1. Home
  2. CVEO vs EBS Comparison

CVEO vs EBS Comparison

Compare CVEO & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Civeo Corporation (Canada)

CVEO

Civeo Corporation (Canada)

N/A

Current Price

$36.06

Market Cap

294.1M

ML Signal

N/A

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

N/A

Current Price

$5.82

Market Cap

303.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CVEO
EBS
Founded
1977
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
294.1M
303.3M
IPO Year
2013
2006

Fundamental Metrics

Financial Performance
Metric
CVEO
EBS
Price
$36.06
$5.82
Analyst Decision
Strong Buy
Buy
Analyst Count
4
3
Target Price
★ $44.41
$10.00
AVG Volume (30 Days)
216.7K
★ 1.1M
Earning Date
10-29-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 125.83
EPS
★ N/A
N/A
Revenue
N/A
★ $742,900,000.00
Revenue This Year
$11.90
N/A
Revenue Next Year
$5.02
$7.03
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$20.97
$4.36
52 Week High
$38.06
$14.06

Technical Indicators

Market Signals
Indicator
CVEO
EBS
Relative Strength Index (RSI) 58.84 38.19
Support Level $31.37 $5.51
Resistance Level $38.06 $6.83
Average True Range (ATR) 2.23 0.45
MACD 0.35 -0.06
Stochastic Oscillator 73.29 15.04

Price Performance

Historical Comparison
CVEO
EBS

About CVEO Civeo Corporation (Canada)

Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, and Australia. It derives maximum revenue from Australia.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: